Empirical Finance, LLC Johnson & Johnson Transaction History

Empirical Finance, LLC

$1.7 Billion
Q3 2024

A detailed history of Empirical Finance, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Empirical Finance, LLC holds 85,434 shares of JNJ stock, worth $12.4 Million. This represents 0.82% of its overall portfolio holdings.

Number of Shares

85,434

Previous 83,780 1.97%

Holding current value

$12.4 Million

Previous $12.2 Million 13.07%

% of portfolio

0.82%

Previous 0.77%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$145.48 - $167.38 $240,623 - $276,846	1,654 Added 1.97%	85,434 $13.8 Million
Q2 2024 Jul 30, 2024	SELL	$144.38 - $157.78 $1.15 Million - $1.25 Million	-7,950 Reduced 8.67%	83,780 $12.2 Million
Q1 2024 May 06, 2024	BUY	$155.22 - $162.74 $415,834 - $435,980	2,679 Added 3.01%	91,730 $14.5 Million
Q3 2023 Nov 02, 2023	BUY	$155.75 - $174.48 $1.06 Million - $1.19 Million	6,812 Added 8.28%	89,051 $13.9 Million
Q2 2023 Jul 27, 2023	BUY	$154.35 - $166.11 $1.37 Million - $1.47 Million	8,869 Added 12.09%	82,239 $13.6 Million
Q1 2023 Apr 05, 2023	BUY	$151.05 - $180.26 $605,257 - $722,301	4,007 Added 5.78%	73,370 $11.4 Million
Q4 2022 Jan 24, 2023	BUY	$160.2 - $179.79 $850,181 - $954,145	5,307 Added 8.28%	69,363 $12.3 Million
Q3 2022 Nov 04, 2022	BUY	$161.33 - $179.52 $1.67 Million - $1.85 Million	10,330 Added 19.23%	64,056 $10.5 Million
Q2 2022 Aug 01, 2022	BUY	$168.19 - $186.01 $471,436 - $521,386	2,803 Added 5.5%	53,726 $9.54 Million
Q1 2022 Apr 21, 2022	BUY	$158.14 - $179.59 $881,788 - $1 Million	5,576 Added 12.3%	50,923 $9.03 Million
Q4 2021 Feb 04, 2022	BUY	$155.93 - $173.01 $1.88 Million - $2.09 Million	12,076 Added 36.3%	45,347 $7.76 Million
Q3 2021 Nov 12, 2021	BUY	$161.5 - $179.47 $301,520 - $335,070	1,867 Added 5.95%	33,271 $5.37 Million
Q2 2021 Aug 10, 2021	BUY	$159.48 - $171.07 $703,625 - $754,760	4,412 Added 16.35%	31,404 $5.17 Million
Q4 2020 Feb 02, 2021	BUY	$137.11 - $157.38 $645,788 - $741,259	4,710 Added 21.14%	26,992 $4.25 Million
Q3 2020 Oct 28, 2020	BUY	$140.38 - $153.83 $2.24 Million - $2.45 Million	15,923 Added 250.4%	22,282 $3.32 Million
Q3 2020 Oct 26, 2020	SELL	$140.38 - $153.83 $1.58 Million - $1.73 Million	-11,249 Reduced 63.89%	6,359 $823,000
Q2 2020 Jul 20, 2020	BUY	$128.81 - $155.51 $637,480 - $769,618	4,949 Added 39.09%	17,608 $2.48 Million
Q2 2020 Jul 20, 2020	SELL	$128.81 - $155.51 $358,349 - $432,628	-2,782 Reduced 18.02%	12,659 $2.48 Million
Q1 2020 Apr 16, 2020	BUY	$111.14 - $153.99 $605,601 - $839,091	5,449 Added 54.53%	15,441 $2.03 Million
Q4 2019 Jan 27, 2020	BUY	$127.5 - $146.44 $463,207 - $532,016	3,633 Added 57.13%	9,992 $1.46 Million
Q3 2019 Oct 30, 2019	BUY	$126.95 - $142.14 $15,234 - $17,056	120 Added 1.92%	6,359 $823,000
Q2 2019 Jul 09, 2019	SELL	$131.15 - $144.24 $3,409 - $3,750	-26 Reduced 0.42%	6,239 $869,000
Q1 2019 May 10, 2019	BUY	$125.72 - $139.79 $182,671 - $203,114	1,453 Added 30.2%	6,265 $876,000
Q4 2018 Jan 22, 2019	SELL	$122.84 - $147.84 $48,767 - $58,692	-397 Reduced 7.62%	4,812 $621,000
Q3 2018 Oct 18, 2018	BUY	$121.58 - $142.88 $71,367 - $83,870	587 Added 12.7%	5,209 $720,000
Q2 2018 Jul 09, 2018	SELL	$119.4 - $131.76 $196,174 - $216,481	-1,643 Reduced 26.23%	4,622 $561,000
Q1 2018 May 10, 2019	BUY	$125.1 - $148.14 $381,930 - $452,271	3,053 Added 95.05%	6,265 $876,000
Q1 2018 Apr 25, 2018	BUY	$125.1 - $148.14 $401,821 - $475,825	3,212 New	3,212 $412,000
Q4 2017 Feb 01, 2018	SELL	$131.22 - $143.62 $531,572 - $581,804	-4,051 Closed	0 $0
Q3 2017 Oct 31, 2017	BUY	$129.47 - $135.38 $44,149 - $46,164	341 Added 9.19%	4,051 $527,000
Q2 2017 Aug 10, 2017	BUY	N/A	3,710	3,710 $491,000

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $379B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Empirical Finance, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empirical Finance, LLC with notifications on news.

Account

Empirical Finance, LLC Johnson & Johnson Transaction History